These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18924343)

  • 1. [Hypertension in dialysis patients].
    Nedbálková M; Soucek M
    Vnitr Lek; 2008 Sep; 54(9):827-34. PubMed ID: 18924343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertension in hemodialyzed uremic patients].
    Sobotová D; Zharfbin A; Svojanovský J; Nedbálková M
    Vnitr Lek; 1999 Nov; 45(11):641-4. PubMed ID: 10951854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension control with daily dialysis.
    Saad E; Charra B; Raj DS
    Semin Dial; 2004; 17(4):295-8. PubMed ID: 15250921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension in patients on hemodialysis: the role of salt intake].
    Tuccillo S; De Nicola L; Minutolo R; Scigliano R; Trucillo P; Avino D; Venditti G; De Luca A; Tirino G; Mascia S; Laurino S; Conte G
    G Ital Nefrol; 2005; 22(5):456-65. PubMed ID: 16267803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of blood pressure in dialyzed patients].
    Kes P; Basić-Jukić N; Jurić I; Brunetta B
    Lijec Vjesn; 2006; 128(11-12):368-73. PubMed ID: 17212199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary sodium restriction for hypertension in dialysis patients.
    Ahmad S
    Semin Dial; 2004; 17(4):284-7. PubMed ID: 15250919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance.
    Twardowski ZJ
    Blood Purif; 2007; 25(1):90-8. PubMed ID: 17170543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume expansion and sodium balance in peritoneal dialysis patients. Part I: Recent concepts in pathogenesis.
    Khandelwal M; Kothari J; Krishnan M; Liakopoulos V; Tziviskou E; Sahu K; Chatalalsingh C; Bargman J; Oreopoulos D
    Adv Perit Dial; 2003; 19():36-43. PubMed ID: 14763032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume expansion and sodium balance in peritoneal dialysis patients. Part II: Newer insights in management.
    Khandelwal M; Kothari J; Krishnan M; Liakopoulos V; Tziviskou E; Sahu K; Chatalalsingh C; Bargman J; Oreopoulos D
    Adv Perit Dial; 2003; 19():44-52. PubMed ID: 14763033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate composition and hemodialysis hypertension.
    Flanigan M
    Semin Dial; 2004; 17(4):279-83. PubMed ID: 15250918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From adequate to optimal dialysis long 3 x 8 hr dialysis: a reasonable compromise.
    Charra B
    Nefrologia; 2005; 25 Suppl 2():19-24. PubMed ID: 16050397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure in haemodialysis patients: the importance of the relationship between the renin-angiotensin-aldosterone system, salt intake and extracellular volume.
    Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):14-22. PubMed ID: 15136968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid balance, dry weight, and blood pressure in dialysis.
    Charra B
    Hemodial Int; 2007 Jan; 11(1):21-31. PubMed ID: 17257351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.
    Kayikcioglu M; Tumuklu M; Ozkahya M; Ozdogan O; Asci G; Duman S; Toz H; Can LH; Basci A; Ok E
    Nephrol Dial Transplant; 2009 Mar; 24(3):956-62. PubMed ID: 19004849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications.
    Blankestijn PJ; Ligtenberg G
    Semin Dial; 2004; 17(4):265-9. PubMed ID: 15250915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium, hypertension, and an explanation of the "lag phenomenon" in hemodialysis patients.
    Twardowski ZJ
    Hemodial Int; 2008 Oct; 12(4):412-25. PubMed ID: 19090863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.